Effect of Preoperative Curcumin in Breast Cancer Patients

NCT03847623 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-03-25

No results posted yet for this study

Summary

Effect of curcumin on modulation of immune and inflammatory parameters in pre-operative patients

Conditions

Interventions

DIETARY_SUPPLEMENT

Curcumin

Natural compound, active ingredient of turmeric, in bi-daily dosing

OTHER

Placebo

Placebo tablets at bi-daily dosing

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Principal Investigators

  • Nur Aishah Taib, MBBS · University of Malaya

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-18
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03847623 on ClinicalTrials.gov